| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |